We are live on ! Find out more
AIMT

Aimmune Therapeutics
AIMT

Delisted

AIMT was delisted on the 12th of October, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Aimmune Therapeutics in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 188 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 188 → 0 (-188)

100% less funds holding in top 10

Funds holding in top 10: 9 → 0 (-9)

100% less capital invested

Capital invested by funds: $1.49B → $0 (-$1.49B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 188

Holders
–
Holders Change
-188
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
188
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$143M
2
BlackRock
BlackRock
New York
-$129M
3
PCM
Pentwater Capital Management
Florida
-$86.2M
4
Goldman Sachs
Goldman Sachs
New York
-$75.8M
5
AAM
Alpine Associates Management
Florida
-$71.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Walleye Capital
76
Walleye Capital
New York
– -$2.35M -68,293 Closed
CSS
77
Cubist Systematic Strategies
Connecticut
– -$2.32M -67,228 Closed
RhumbLine Advisers
78
RhumbLine Advisers
Massachusetts
– -$2.31M -67,157 Closed
AC
79
Athanor Capital
New York
– -$2.24M -65,000 Closed
NAM
80
Nexpoint Asset Management
Texas
– -$2.16M -62,591 Closed
Royal Bank of Canada
81
Royal Bank of Canada
Ontario, Canada
– -$2.12M -61,571 Closed
Ameriprise
82
Ameriprise
Minnesota
– -$2.08M -60,497 Closed
SB
83
Samsara BioCapital
California
– -$2M -58,142 Closed
WG
84
Winton Group
United Kingdom
– -$1.98M -57,453 Closed
Skandinaviska Enskilda Banken (SEB)
85
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$1.87M -54,407 Closed
Qube Research & Technologies (QRT)
86
Qube Research & Technologies (QRT)
United Kingdom
– -$1.78M -51,590 Closed
Marshall Wace
87
Marshall Wace
United Kingdom
– -$1.76M -51,013 Closed
HF
88
HRT Financial
New York
– -$1.69M -48,966 Closed
Rafferty Asset Management
89
Rafferty Asset Management
New York
– -$1.61M -46,846 Closed
YCM
90
Yakira Capital Management
Connecticut
– -$1.61M -46,826 Closed
New York State Common Retirement Fund
91
New York State Common Retirement Fund
New York
– -$1.47M -42,600 Closed
WRBC
92
W.R. Berkley Corp
Connecticut
– -$1.37M -39,789 Closed
GC
93
Guggenheim Capital
Illinois
– -$1.36M -39,629 Closed
UBS AM
94
UBS AM
Illinois
– -$1.34M -38,944 Closed
Ohio Public Employees Retirement System (OPERS)
95
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$1.24M -36,000 Closed
Squarepoint
96
Squarepoint
New York
– -$1.19M -34,600 Closed
VEA
97
Virtus ETF Advisers
New York
– -$1.13M -32,688 Closed
State Board of Administration of Florida Retirement System
98
State Board of Administration of Florida Retirement System
Florida
– -$994K -28,862 Closed
Legal & General Group
99
Legal & General Group
United Kingdom
– -$980K -28,450 Closed
AIG
100
American International Group
New York
– -$958K -27,804 Closed
2 3
4
5 6

AIMT Hedge Fund Activity: Q4 2020 in Review

0 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Aimmune Therapeutics (AIMT) for Q4 2020, worth a combined $0 — down 100% from $1.49B a quarter earlier.

Sellers outnumbered buyers: 188 funds closed out of AIMT and 0 opened new positions — a net loss of 188 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $143M sold.

  • 0 institutional investors held Aimmune Therapeutics (AIMT) as of Q4 2020, down from 188 in Q3 2020.
  • Funds reported $0 of Aimmune Therapeutics stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Aimmune Therapeutics positions in Q4 2020 and 188 closed out, a net change of -188 holders.
  • The largest Aimmune Therapeutics seller in Q4 2020 was Vanguard Group, an estimated $143M sold.

Based on aggregated 13F filings for Q4 2020.